6 results
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
/LABA/ICS) - ... /LABA) & Eosinophils ... recommendations for the treatment ... won’t have any clinical ... #Pharmacology #
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... disease b) CHF ... Change in clinical ... Determine if any labs ... unless prior heart/lung
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... is vital while lab ... & Dry) is the treatment ... #heartfailure #chf ... #pharmacology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Ocular examination Labs ... salivary ducts Clinical ... MALT Lymphoma • Lung ... Adenocarcinoma Treatment ... lubricants • Pharmacologic
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
effects in the treatment ... Weaknesses: Limited clinical ... Antifungal #agents #medications ... Coccidioidomycosis #pharmacology ... #management #treatment
Mycoses

HISTOPLASMOSIS
• Inhalation of conidia → Yeast → travel to lymph nodes → spread in body
• Bird
has five major clinical ... Diagnosis: • Labs ... fungal stain of clinical ... change in the lungs ... nails, bronchi, lungs